Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

(2012) George Miller et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Bile-Based Detection of Extrahepatic Cholangiocarcinoma with Quantitative DNA Methylation Markers and Its High Sensitivity

(2012) So-Hyun Shin et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

CpG-island methylation study of liver fluke-related cholangiocarcinoma

(2011) R Sriraksa et al.   BRITISH JOURNAL OF CANCER

DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism

(2011) S. M. Sureban et al.   CANCER RESEARCH

Promoter methylation of Wnt antagonistsDKK1andSFRP1is associated with opposing tumor subtypes in two large populations of colorectal cancer patients

(2011) James B. Rawson et al.   CARCINOGENESIS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Epigenetic aberrations during oncogenesis

(2011) Maria Hatziapostolou et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour

(2011) Mariana Maschietto et al.   EUROPEAN JOURNAL OF CANCER

Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma

(2011) Zhao-Hui Huang et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas

(2011) Bodil Øster et al.   INTERNATIONAL JOURNAL OF CANCER

Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer

(2011) Yong-Jae Kwon et al.   Journal of Thoracic Oncology

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

(2011) Guro E Lind et al.   Molecular Cancer

Long Term Transcriptional Reactivation of Epigenetically Silenced Genes in Colorectal Cancer Cells Requires DNA Hypomethylation and Histone Acetylation

(2011) David Mossman et al.   PLoS One

CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

(2010) Dimo Dietrich et al.   BMC CANCER

Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples

(2010) V. L. Costa et al.   CLINICAL CANCER RESEARCH

Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma

(2010) M R Morris et al.   ONCOGENE

Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer

(2010) Victoria Gonzalo et al.   PLoS One

Promoter CpG island hypermethylation during breast cancer progression

(2010) So Yeon Park et al.   VIRCHOWS ARCHIV

Promoter methylation and the detection of breast cancer

(2009) Jennifer Brooks et al.   CANCER CAUSES & CONTROL

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acid, Bile, and CDX: the ABCs of making Barrett's metaplasia

(2008) Rhonda F. Souza et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Cholangiocarcinoma: lessons from Thailand

(2008) Banchob Sripa et al.   CURRENT OPINION IN GASTROENTEROLOGY

Circulating markers of biliary malignancy: opportunities in proteomics?

(2008) Glenn K Bonney et al.   LANCET ONCOLOGY

Aberrant Promoter CpG Islands Methylation of Tumor Suppressor Genes in Cholangiocarcinoma

(2008) Kyung-Ok Uhm et al.   ONCOLOGY RESEARCH

DNA methylation and cancer pathways in gastrointestinal tumors

(2008) Hiromu Suzuki et al.   PHARMACOGENOMICS